LENSAR, Inc. (LNSR): Total Liabilities
$83.67M
As of 2025-12-31
$40.87M
As of 2026-06-30
+82.1%
3-year compound annual growth
+47.7%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $83.67M | +75.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $47.65M | +112.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $22.41M | +61.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $13.86M | +19.6% | 2024-03-04, Balance as of period end |
| 2021-12-31 | $11.59M | -2.7% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $11.91M | -81.7% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $65.09M | n/a | 2021-03-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $83.67M | +75.6% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $65.47M | +5.0% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2024-12-31 | $27.26M | +8.7% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $52.01M | +3.0% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $31.25M | +19.2% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $73.04M | -2.6% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $29.16M | +25.1% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $69.19M | +38.8% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $51.36M | -7.2% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗